New Jersey Clinical Compliance Specialist
Exam Question and correct
answers (verified answers 100%) Q&A
2026/2027 INSTANT DOWNLOAD PDF
1. Which action is MOST appropriate for a Clinical Compliance Specialist
when a clinical research site identifies a potential protocol deviation?
A. Ignore it if no patient was harmed
B. Immediately delete the related documentation
C. Document, assess, and report the deviation according to applicable procedures
D. Change the protocol retrospectively without approval
Correct Answer: C. Document, assess, and report the deviation according to
applicable procedures.
Rationale: Protocol deviations should be appropriately documented and assessed
to determine their impact on participant safety, data integrity, and regulatory
compliance. Reporting should follow the study protocol, institutional procedures,
and applicable regulatory requirements.
New Jersey Clinical Compliance Specialist Exam — Questions 2–100
2. Which document describes the procedures and objectives of a clinical trial?
A. Investigator brochure
B. Clinical study protocol
C. Pharmacy log
D. Financial disclosure form
Correct Answer: B. Clinical study protocol
1
,Rationale: The clinical study protocol defines the study objectives, design,
methodology, eligibility requirements, procedures, and statistical considerations.
3. What is the primary purpose of Good Clinical Practice (GCP)?
A. Reduce research costs
B. Protect participants and ensure reliable clinical-trial data
C. Increase recruitment speed
D. Eliminate monitoring visits
Correct Answer: B. Protect participants and ensure reliable clinical-trial data
Rationale: GCP establishes ethical and scientific quality standards that protect
trial participants and support the credibility and integrity of clinical-trial results.
4. Which organization primarily regulates clinical investigations of drugs and
biologics in the United States?
A. OSHA
B. FDA
C. EPA
D. CMS
Correct Answer: B. FDA
Rationale: The U.S. Food and Drug Administration regulates clinical
investigations involving drugs, biologics, medical devices, and other FDA-
regulated products.
5. What is the main responsibility of an Institutional Review Board (IRB)?
A. Approve investigator salaries
B. Protect the rights and welfare of research participants
C. Manufacture investigational products
D. Analyze company revenue
2
,Correct Answer: B. Protect the rights and welfare of research participants
Rationale: IRBs independently review research to protect participant rights, safety,
and welfare and to ensure ethical conduct.
6. Before enrolling a participant in a clinical trial, what generally must be
obtained?
A. Insurance approval only
B. Informed consent
C. Laboratory certification
D. Sponsor payment confirmation
Correct Answer: B. Informed consent
Rationale: Informed consent must generally be obtained before participation,
except when an appropriately authorized regulatory or IRB exception applies.
7. What is the best description of informed consent?
A. A one-time financial agreement
B. A process through which participants receive information and voluntarily agree
to participate
C. A waiver of all participant rights
D. A sponsor authorization document
Correct Answer: B. A process through which participants receive information
and voluntarily agree to participate
Rationale: Informed consent is an ongoing ethical process involving adequate
information, understanding, and voluntary participation.
8. Which situation represents a serious breach of confidentiality?
A. Storing coded research data securely
B. Sharing identifiable participant information with unauthorized individuals
3
, C. Using participant identification numbers
D. Restricting database access
Correct Answer: B. Sharing identifiable participant information with
unauthorized individuals
Rationale: Unauthorized disclosure of identifiable participant information can
violate privacy protections and institutional or regulatory requirements.
9. What is the primary purpose of source documentation?
A. Increase study enrollment
B. Provide evidence supporting clinical-trial data and activities
C. Replace informed consent
D. Advertise the study
Correct Answer: B. Provide evidence supporting clinical-trial data and
activities
Rationale: Source documents provide evidence of the existence and integrity of
clinical-trial data and participant-related activities.
10. Which principle requires clinical-trial records to be attributable, legible,
contemporaneous, original, and accurate?
A. ALCOA principles
B. HIPAA principles
C. OSHA principles
D. COBRA principles
Correct Answer: A. ALCOA principles
Rationale: ALCOA is a widely used framework for assessing the integrity of
regulated records.
11. What does the “A” in ALCOA represent?
4
Exam Question and correct
answers (verified answers 100%) Q&A
2026/2027 INSTANT DOWNLOAD PDF
1. Which action is MOST appropriate for a Clinical Compliance Specialist
when a clinical research site identifies a potential protocol deviation?
A. Ignore it if no patient was harmed
B. Immediately delete the related documentation
C. Document, assess, and report the deviation according to applicable procedures
D. Change the protocol retrospectively without approval
Correct Answer: C. Document, assess, and report the deviation according to
applicable procedures.
Rationale: Protocol deviations should be appropriately documented and assessed
to determine their impact on participant safety, data integrity, and regulatory
compliance. Reporting should follow the study protocol, institutional procedures,
and applicable regulatory requirements.
New Jersey Clinical Compliance Specialist Exam — Questions 2–100
2. Which document describes the procedures and objectives of a clinical trial?
A. Investigator brochure
B. Clinical study protocol
C. Pharmacy log
D. Financial disclosure form
Correct Answer: B. Clinical study protocol
1
,Rationale: The clinical study protocol defines the study objectives, design,
methodology, eligibility requirements, procedures, and statistical considerations.
3. What is the primary purpose of Good Clinical Practice (GCP)?
A. Reduce research costs
B. Protect participants and ensure reliable clinical-trial data
C. Increase recruitment speed
D. Eliminate monitoring visits
Correct Answer: B. Protect participants and ensure reliable clinical-trial data
Rationale: GCP establishes ethical and scientific quality standards that protect
trial participants and support the credibility and integrity of clinical-trial results.
4. Which organization primarily regulates clinical investigations of drugs and
biologics in the United States?
A. OSHA
B. FDA
C. EPA
D. CMS
Correct Answer: B. FDA
Rationale: The U.S. Food and Drug Administration regulates clinical
investigations involving drugs, biologics, medical devices, and other FDA-
regulated products.
5. What is the main responsibility of an Institutional Review Board (IRB)?
A. Approve investigator salaries
B. Protect the rights and welfare of research participants
C. Manufacture investigational products
D. Analyze company revenue
2
,Correct Answer: B. Protect the rights and welfare of research participants
Rationale: IRBs independently review research to protect participant rights, safety,
and welfare and to ensure ethical conduct.
6. Before enrolling a participant in a clinical trial, what generally must be
obtained?
A. Insurance approval only
B. Informed consent
C. Laboratory certification
D. Sponsor payment confirmation
Correct Answer: B. Informed consent
Rationale: Informed consent must generally be obtained before participation,
except when an appropriately authorized regulatory or IRB exception applies.
7. What is the best description of informed consent?
A. A one-time financial agreement
B. A process through which participants receive information and voluntarily agree
to participate
C. A waiver of all participant rights
D. A sponsor authorization document
Correct Answer: B. A process through which participants receive information
and voluntarily agree to participate
Rationale: Informed consent is an ongoing ethical process involving adequate
information, understanding, and voluntary participation.
8. Which situation represents a serious breach of confidentiality?
A. Storing coded research data securely
B. Sharing identifiable participant information with unauthorized individuals
3
, C. Using participant identification numbers
D. Restricting database access
Correct Answer: B. Sharing identifiable participant information with
unauthorized individuals
Rationale: Unauthorized disclosure of identifiable participant information can
violate privacy protections and institutional or regulatory requirements.
9. What is the primary purpose of source documentation?
A. Increase study enrollment
B. Provide evidence supporting clinical-trial data and activities
C. Replace informed consent
D. Advertise the study
Correct Answer: B. Provide evidence supporting clinical-trial data and
activities
Rationale: Source documents provide evidence of the existence and integrity of
clinical-trial data and participant-related activities.
10. Which principle requires clinical-trial records to be attributable, legible,
contemporaneous, original, and accurate?
A. ALCOA principles
B. HIPAA principles
C. OSHA principles
D. COBRA principles
Correct Answer: A. ALCOA principles
Rationale: ALCOA is a widely used framework for assessing the integrity of
regulated records.
11. What does the “A” in ALCOA represent?
4
